Jerald Cobbs - Bioject Medical Independent Director
Director
Mr. Jerald S. Cobbs is Independent Director of Bioject Medical Technologies Inc. He has served as a director since March 2006 and as Chairman of the Board from October 2006 until February 2008. Mr. Cobbs has the experience in the health sciences and biotechnology sector to the Board. From March 2007 to September 2008 Mr. Cobbs was appointed as the Interim President and Chief Executive Officer. Mr. Cobbs is Chief Commercialization Officer of the Cancer Prevention Research Institute of Texas . Mr. Cobbs was a Managing Director of Signet Healthcare Partners from 2001 until March 2009. Mr. Cobbs has more than twenty five years experience in the health sciences and biotechnology industries. Mr. Cobbs previously served as the Assistant Director of Technology Development at the University of Texas M.D. Anderson Cancer Center in the Houston Medical Center. During his tenure at M.D. Anderson Cancer Center he helped form two molecular therapy companies Introgen Therapeutics a pioneer in genebased therapies for a variety of cancers based in Austin Texas and Rgene Therapeutics which was sold to Targeted Genetics Inc. . Mr. Cobbs was also Chairman and Chief Executive Officer of Quantitative Diagnostic Laboratories a cancer diagnostic and image analysis company based in Chicago IL since 2008.
| Age | 61 |
| Tenure | 16 years |
| Professional Marks | MBA |
| Phone | 503-692-8001 |
| Web | http://www.bioject.com |
Bioject Medical Management Efficiency
The company has return on total asset (ROA) of (15.05) % which means that it has lost $15.05 on every $100 spent on assets. This is way below average. Bioject Medical's management efficiency ratios could be used to measure how well Bioject Medical manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 225 K in liabilities with Debt to Equity (D/E) ratio of 0.21, which may suggest the company is not taking enough advantage from borrowing. Bioject Medical Tech has a current ratio of 0.65, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bioject Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Bioject Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioject Medical Tech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioject to invest in growth at high rates of return. When we think about Bioject Medical's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Chang Lee | POSCO Holdings | 54 | |
| Pedro Kuczynski | Ternium SA ADR | 76 | |
| Bruno Marchettini | Ternium SA ADR | 71 | |
| Vincent Decalf | Ternium SA ADR | 57 | |
| Adrian Lajous | Ternium SA ADR | 76 | |
| Peter Kaufman | Daily Journal Corp | 63 | |
| Peter Burgess | Lincoln Educational Services | 76 | |
| Oscar Martinez | Ternium SA ADR | 64 | |
| Luis Andreozzi | Ternium SA ADR | 62 | |
| Jae Shin | POSCO Holdings | 69 | |
| Ubaldo Aguirre | Ternium SA ADR | 71 | |
| Carlos Condorelli | Ternium SA ADR | 68 | |
| Ruben Herrera | Ternium SA ADR | 62 | |
| Gianfelice Rocca | Ternium SA ADR | 71 | |
| James Burke | Lincoln Educational Services | 63 | |
| Seung Jang | POSCO Holdings | 57 | |
| James Bemowski | POSCO Holdings | 60 | |
| Gary Wilcox | Daily Journal Corp | 70 | |
| Ju Kim | POSCO Holdings | 67 | |
| Seong Kim | POSCO Holdings | 71 | |
| Byeong Park | POSCO Holdings | 67 | |
Management Performance
| Return On Asset | -15.05 |
Bioject Medical Tech Leadership Team
Elected by the shareholders, the Bioject Medical's board of directors comprises two types of representatives: Bioject Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioject. The board's role is to monitor Bioject Medical's management team and ensure that shareholders' interests are well served. Bioject Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioject Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Tierney, Independent Director | ||
| Richard Stout, Executive Vice President Chief Medical Officer, Member of Executive Committee | ||
| Tony Chow, CEO and President and Director | ||
| Edward Flynn, Independent Director | ||
| Ralph Makar, Director | ||
| Jerald Cobbs, Independent Director |
Bioject Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bioject Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -15.05 | |||
| Profit Margin | (86.55) % | |||
| Operating Margin | (62.35) % | |||
| Current Valuation | 2.35 M | |||
| Shares Outstanding | 18.91 M | |||
| Shares Owned By Insiders | 112.39 % | |||
| Shares Owned By Institutions | 0.50 % | |||
| Number Of Shares Shorted | 6.22 K | |||
| Price To Earning | 8.89 X | |||
| Price To Sales | 0.01 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bioject Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bioject Medical's short interest history, or implied volatility extrapolated from Bioject Medical options trading.
Pair Trading with Bioject Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioject Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioject Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Johnson Johnson could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Johnson Johnson when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Johnson Johnson - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Johnson Johnson to buy it.
The correlation of Johnson Johnson is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Johnson Johnson moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Johnson Johnson moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Johnson Johnson can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Bioject Medical Tech information on this page should be used as a complementary analysis to other Bioject Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Bioject Stock
If you are still planning to invest in Bioject Medical Tech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioject Medical's history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |